67559-1-Ig
antibody from Proteintech Group
Targeting: SUMO1
GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67559-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- SUMO1 antibody
- Antibody type
- Monoclonal
- Description
- SUMO1 antibody (Cat. #67559-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Mouse, Rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 3B5B5
- Vial size
- 20ul, 150ul
Submitted references SENP1 inhibits aerobic glycolysis in Aβ(1-42)-incubated astrocytes by promoting PUM2 deSUMOylation.
FOXL2 + cancer-associated fibroblasts enhances epithelial ovarian cancer development via TGFβ/Smad signaling.
The mitochondrial E3 ligase MAPL SUMOylates Drp1 to facilitate mitochondrial fission in intervertebral disc degeneration.
Isoginkgetin and Madrasin are poor splicing inhibitors.
Hydrogen sulfide regulates SERCA2a SUMOylation by S-Sulfhydration of SENP1 to ameliorate cardiac systole-diastole function in diabetic cardiomyopathy.
Liu Q, Jiang M, Wang Z, Meng J, Jia H, Li J, Lin J, Guo L, Gao L
Cell biology and toxicology 2025 Jan 10;41(1):28
Cell biology and toxicology 2025 Jan 10;41(1):28
FOXL2 + cancer-associated fibroblasts enhances epithelial ovarian cancer development via TGFβ/Smad signaling.
Zhao L, Nie J, Wang J, Li D, Hao X
BMC cancer 2025 Dec 23;26(1):147
BMC cancer 2025 Dec 23;26(1):147
The mitochondrial E3 ligase MAPL SUMOylates Drp1 to facilitate mitochondrial fission in intervertebral disc degeneration.
Lin Z, Lu X, Xu G, Song J, Wang H, Xia X, Lu F, Jiang J, Zhu W, Yu Z, Ma X, Zou F
Bone research 2025 Aug 12;13(1):72
Bone research 2025 Aug 12;13(1):72
Isoginkgetin and Madrasin are poor splicing inhibitors.
Tellier M, Ansa G, Murphy S
PloS one 2024;19(10):e0310519
PloS one 2024;19(10):e0310519
Hydrogen sulfide regulates SERCA2a SUMOylation by S-Sulfhydration of SENP1 to ameliorate cardiac systole-diastole function in diabetic cardiomyopathy.
Peng S, Wang M, Zhang S, Liu N, Li Q, Kang J, Chen L, Li M, Pang K, Huang J, Lu F, Zhao D, Zhang W
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 Apr;160:114200
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 Apr;160:114200
No comments: Submit comment
No validations: Submit validation data